Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 100,000 shares at $53.13 ($5.4M) on 2020-11-02, disclosed to the SEC on 2020-11-03.
Open-market sale of $5.4M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.13 | 29,073 | $1.5M | 28.8% |
| 2 | $53.13 | 29,073 | $1.5M | 28.8% |
| 3 | $53.86 | 9,114 | $491K | 9.1% |
| 4 | $53.86 | 9,114 | $491K | 9.1% |
| 5 | $54.79 | 11,813 | $647K | 12.1% |
| 6 | $54.79 | 11,813 |
| $647K |
| 12.1% |
| Total | $53.66 avg | 100,000 | $5.4M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |